Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 150 of 521 entries
View as:

Bioequivalence Evaluation of a New and Current Tablet of ASP015K

Phase: N/A Priority: Normal
NCT ID: NCT02531191 Org: User:
Start: 06/21/15 End: 07/15/15 Due: 07/15/16

A Study to Compare the Effect of ASP3550 With Goserelin in Patients With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01964170 Org: User:
Start: 08/13/13 End: 08/08/16 Due: 08/08/17

To Evaluate Whether Naproxen and Darexaban (YM150) Interact in Their Effects

Phase: N/A Priority: Normal
NCT ID: NCT01409603 Org: User:
Start: 01/31/10 End: 05/31/10 Due: 05/31/11

A Comparative Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis

Phase: N/A Priority: Normal
NCT ID: NCT01057407 Org: User:
Start: 01/31/10 End: 09/30/10 Due: 09/30/11

Dose-Escalating and Safety Study of CP-461 in Patients With Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00036257 Org: User:
Start: 03/31/02 End: 04/30/03 Due: 04/30/04

A Study to Evaluate Response of Over Active Bladder Symptom Score to Solifenacin Treatment

Phase: N/A Priority: Normal
NCT ID: NCT01318837 Org: User:
Start: 04/30/10 End: 09/30/11 Due: 09/30/12

Post-Marketing Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Ipragliflozin in Combination With GLP-1 Receptor Agonists in Japanese Patients With Type 2 Diabetes Mellitus (T2DM)

Phase: N/A Priority: Normal
NCT ID: NCT02291874 Org: User:
Start: 10/08/14 End: 07/07/16 Due: 07/07/17

Assess the Long-term Effectiveness and Safety of Amevive (Alefacept) in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT00795353 Org: User:
Start: 07/31/08 End: 01/31/11 Due: 01/31/12

Study to Evaluate the Response to Treatment and Safety of 0.03% Tacrolimus (FK506) Ointment Administered in Pediatric Patients With Moderate to Severe Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT00691262 Org: User:
Start: 10/31/03 End: 02/28/05 Due: 02/28/06

Study of Mycamine® in Infants and Toddlers With Fungal Infections to Evaluate Safety and Blood Levels of the Drug

Phase: N/A Priority: Normal
NCT ID: NCT00607763 Org: User:
Start: 10/31/07 End: 10/31/09 Due: 10/31/10

An Open Study Assessing Bioavailability of a Modified Formulation of Tacrolimus in Kidney Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT00865137 Org: User:
Start: 09/30/07 End: 12/31/07 Due: 12/31/08

A Study to Evaluate the Tolerability and Efficacy of Tamsulosin 0.4mg OCAS Formulation in Patients Who Are Unsatisfied With the Treatment of Tamsulosin 0.2mg Conventional Formulation

Phase: N/A Priority: Normal
NCT ID: NCT02180789 Org: User:
Start: 03/31/13 End: 01/31/15 Due: 01/31/16

A Study to Assess the Efficacy and Safety of ASP1941 in Japanese Type 2 Diabetes Patients

Phase: N/A Priority: Normal
NCT ID: NCT01057628 Org: User:
Start: 01/13/10 End: 11/06/10 Due: 11/06/11

Post-marketing Surveillance of Kiklin Capsules in Hemodialysis Patients

Phase: N/A Priority: Normal
NCT ID: NCT01901107 Org: User:
Start: 01/31/13 End: 12/31/16 Due: 12/31/17

Solifenacin as Add-on Therapy for Overactive Bladder Symptoms in Men Treated for Benign Prostatic Hyperplasia

Phase: N/A Priority: Normal
NCT ID: NCT00771394 Org: User:
Start: 10/31/08 End: 01/31/10 Due: 01/31/11

A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes

Phase: N/A Priority: Normal
NCT ID: NCT00486200 Org: User:
Start: 06/21/07 End: 08/12/08 Due: 08/12/09

A Randomized Study to Evaluate FK962 in Subjects With Mild to Moderate Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00087724 Org: User:
Start: 07/31/04 End: 09/30/06 Due: 09/30/07

ASP8825 - Study in Patients With Restless Legs Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00530530 Org: User:
Start: 09/30/07 End: 01/31/09 Due: 01/31/10

A Study of FK199B to Compare Efficacy With Zolpidem by Polysomnography in Patients With Insomnia

Phase: N/A Priority: Normal
NCT ID: NCT00999219 Org: User:
Start: 03/31/06 End: 07/31/07 Due: 07/31/08

Pilot Trial in Sleep Laboratory Setting to Compare the Physiology of Night Time Bladder Function in Subjects With Overactive Bladder (OAB) Versus Subjects That Have Insomnia and Healthy Normal Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01029015 Org: User:
Start: 11/30/06 End: 07/31/07 Due: 07/31/08

Dose Range-finding Study of ASP1585 in Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia

Phase: N/A Priority: Normal
NCT ID: NCT02753894 Org: User:
Start: 01/31/08 End: 06/30/08 Due: 06/30/09

A Study to Assess Intraocular Pressure and Ocular Safety of the Beta-3 Agonist Mirabegron in Research Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01284309 Org: User:
Start: 11/30/10 End: 02/28/11 Due: 02/28/12

A Study to Assess the Bioavailability of ASP015K

Phase: N/A Priority: Normal
NCT ID: NCT01430078 Org: User:
Start: 09/30/10 End: 10/31/10 Due: 10/31/11

A Study of the Safety and Pharmacokinetics of AGS-22M6E in Subjects With Malignant Solid Tumors That Express Nectin-4

Phase: N/A Priority: Normal
NCT ID: NCT01409135 Org: User:
Start: 07/11/11 End: 04/27/15 Due: 04/27/16

A Phase 4 Study With Tamsulosin OCAS to Assess Nighttime Voiding.

Phase: N/A Priority: Normal
NCT ID: NCT00379067 Org: User:
Start: 10/31/05 End: 11/30/06 Due: 11/30/07